Successful treatment of ifosfamide-induced hyponatremia with AVP receptor antagonist without interruption of hydration for prevention of hemorrhagic cystitis.
Glezerman
I G
IG
D000328:Adult; D065092:Antidiuretic Hormone Receptor Antagonists; D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001552:Benzazepines / Q000627:therapeutic use*; D003556:Cystitis / Q000517:prevention & control; D005440:Fluid Therapy; D006801:Humans; D007069:Ifosfamide / Q000009:adverse effects*; D007177:Inappropriate ADH Syndrome / Q000139:chemically induced / Q000175:diagnosis / Q000188:drug therapy*; D016483:Lymphoma, AIDS-Related / Q000188:drug therapy; D008297:Male
D065092:Antidiuretic Hormone Receptor Antagonists; D018906:Antineoplastic Agents, Alkylating; D001552:Benzazepines; C106389:conivaptan; D007069:Ifosfamide